Opus Genetics Inc Asset Turnover Ratio (IRD), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Opus Genetics Inc   (NASDAQ: IRD)
 

Opus Genetics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the first quarter 2026, Opus Genetics Inc 's asset turnover ratio sequentially decreased to 0.25 in the first quarter (Mar 31 2026), this is lower than usual.

Within sector 117 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 2268 to 2720.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IRD Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change 38.66 % 36.3 % -7.05 % -13.76 % -7.09 %
Y / Y Revenue Change -50.64 % -10.16 % -20.38 % 159.17 % 155.41 %
Asset Turnover Ratio (TTM) 0.25 0.33 0.37 0.38 0.32
IRD's Total Ranking # 2720 # 2268 # 0 # 0 # 0
Seq. Asset Change 32.93 % 39.09 % -6.58 % -19.73 % 30.67 %
Seq. Revenue Change -44.19 % 25.53 % 6.84 % -34.05 % 1.58 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 118
Healthcare Sector # 389
Overall Market # 2720

Asset Turnover Ratio Statistics
High Average Low
15.89 6.12 4.52
(Sep 30 2023)   (Sep 30 2025)




IRD Company Profile • Back to IRD Efficiency Comparisons • Compare IRD Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Emergent Biosolutions Inc   0.49 $ 676.800  Millions$ 1,379.275  Millions
Johnson and Johnson  0.49 $ 96,362.000  Millions$ 196,577.250  Millions
American Shared Hospital Services  0.49 $ 28.410  Millions$ 58.332  Millions
Vertex Pharmaceuticals Inc  0.48 $ 12,218.000  Millions$ 25,256.600  Millions
Ceribell Inc   0.48 $ 94.389  Millions$ 195.274  Millions
Fonar Corporation  0.48 $ 105.338  Millions$ 217.926  Millions
Rhythm Pharmaceuticals Inc   0.48 $ 217.165  Millions$ 450.530  Millions
Orthopediatrics Corp  0.48 $ 241.789  Millions$ 501.978  Millions
Ge Healthcare Technologies Inc   0.48 $ 17,475.000  Millions$ 36,414.500  Millions
Boston Scientific Corporation  0.48 $ 20,616.000  Millions$ 43,072.500  Millions
Xenetic Biosciences Inc   0.48 $ 3.190  Millions$ 6.674  Millions
Sbc Medical Group Holdings Incorporated  0.48 $ 167.536  Millions$ 351.282  Millions
Aurinia Pharmaceuticals Inc   0.48 $ 298.295  Millions$ 626.419  Millions
Pacific Health Care Organization Inc  0.48 $ 6.394  Millions$ 13.459  Millions
Bio techne Corp  0.48 $ 1,210.490  Millions$ 2,548.121  Millions
Edwards Lifesciences Corporation  0.47 $ 6,303.300  Millions$ 13,444.825  Millions
Organon and Co   0.47 $ 6,175.000  Millions$ 13,228.750  Millions
Abbvie Inc   0.46 $ 62,819.000  Millions$ 135,375.750  Millions
Glaukos Corp  0.46 $ 437.645  Millions$ 943.287  Millions
Aytu Biopharma Inc  0.46 $ 55.663  Millions$ 120.714  Millions
Perrigo Company Plc  0.46 $ 4,177.500  Millions$ 9,174.150  Millions
Vireo Growth Inc.  0.45 $ 350.469  Millions$ 771.053  Millions
Collegium Pharmaceutical Inc   0.45 $ 739.250  Millions$ 1,627.187  Millions
Rapid Micro Biosystems Inc   0.45 $ 33.753  Millions$ 74.302  Millions
Integra Lifesciences Holdings Corp  0.45 $ 1,644.510  Millions$ 3,623.521  Millions
Quidelortho Corp  0.45 $ 2,657.200  Millions$ 5,863.050  Millions
Sangamo Therapeutics Inc   0.45 $ 34.557  Millions$ 76.478  Millions
Sutro Biopharma Inc   0.45 $ 99.608  Millions$ 221.958  Millions
Amphastar Pharmaceuticals Inc   0.44 $ 720.530  Millions$ 1,639.754  Millions
Outset Medical Inc   0.43 $ 116.783  Millions$ 270.002  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.